|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/06 | |||
| A61K 9/10 | |||
| A61K 9/16 | |||
| A61K 47/34 | |||
| A61K 38/31 |
| (11) | Patento numeris | 2247282 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09705454.8 |
| Europos patento paraiškos padavimo data | 2009-01-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-11-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-08-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/051026 |
| Data | 2009-01-29 |
| (87) | Numeris | WO 2009/095450 |
| Data | 2009-08-06 |
| (30) | Numeris | Data | Šalis |
| 08150826 | 2008-01-30 | EP |
| (72) |
PETERSEN, Holger, DE
AHLHEIM, Markus, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS |
| SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS |